1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGrants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) is sponsored by National Institute on Aging (NIA). Supports early-career physician-scientists in medical or surgical specialties to transition into aging research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) Agency: National Institutes of Health Assistance Listings: 93. 866 -- Aging Research Last Updated: May 13, 2026 View version history on Grants.
gov The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to renew the Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) program.
The GEMSSTAR program provides support for early-career physician-scientists trained in medical or surgical specialties and early-career dentist-scientists in launching careers as future leaders in aging- or geriatric-focused research. As such, the program seeks applicants who aspire to continue or shift their research focus to bridge their specialty/discipline and the clinical care of older adults.
In support of the program's goal, this NOFO invites applications that propose to conduct transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects.
The GEMSSTAR program encourages candidates to seek out a supportive research environment to further the program's objectives of fostering the development of early-career physician- and dentist-scientists in aging- or geriatric-focused research, particularly as it applies to their clinical specialty/discipline. Applications are not being solicited at this time.
Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO intends to utilize the R03 activity code.
For-profit organizations other than small businesses Private institutions of higher education Public and state institutions of higher education Independent school districts Public and Indian housing authorities Federally recognized Native American tribal governments Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Grantor contact information National Institute on Aging (NIA) No documents are currently available.
Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Early-career physician-scientists trained in medical or surgical specialties and early-career dentist-scientists. Confirm the full requirements in the official notice before applying.
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) is funded by National Institute on Aging (NIA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article